DexCom, Inc. (LON:0A4M)
London · Delayed Price · Currency is GBP · Price in USD 65.67
0.00 (0.00%)
At close: Oct 10, 2025
DexCom Market Cap
DexCom has a market cap or net worth of 19.99 billion as of October 21, 2025. Its market cap has decreased by -1.39% in one year.
Market Cap
19.99B
Enterprise Value
19.73B
Revenue
3.14B
Ranking
n/a
PE Ratio
47.92
Stock Price
65.67
Market Cap Chart
Since April 14, 2005, DexCom's market cap has increased from 157.23M to 19.99B, an increase of 12,612.97%. That is a compound annual growth rate of 26.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 19.50B | -19.64% |
| Dec 31, 2024 | 24.26B | -35.54% |
| Dec 29, 2023 | 37.64B | 3.69% |
| Dec 30, 2022 | 36.30B | -5.55% |
| Dec 31, 2021 | 38.43B | 47.80% |
| Dec 31, 2020 | 26.00B | 72.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.74B |
| HSBC Holdings | 165.53B |
| Shell | 155.89B |
| Unilever | 116.14B |
| Rolls-Royce Holdings | 92.83B |
| Rio Tinto Group | 86.80B |
| British American Tobacco p.l.c. | 83.57B |
| GSK plc | 65.34B |